Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data
Offer Amir, Gabby Elbaz-Greener, Shemy Carasso, Brian Claggett, Olga Barbarash, Azfar Zaman, Christina Christersson, Songsak Kiatchoosakun, John Anonuevo, Grzegorz Opolski, Mody F. Vaghaiwalla, Peter van der Meer, Yinong Zhou, Douglas L. Mann, Lars Kober, Gabriel Steg, Karola Jering, Ian Kulac, Carmine G. De Pasquale, John J.V. McMurray, Marc A. Pfeffer
{"title":"Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data","authors":"Offer Amir, Gabby Elbaz-Greener, Shemy Carasso, Brian Claggett, Olga Barbarash, Azfar Zaman, Christina Christersson, Songsak Kiatchoosakun, John Anonuevo, Grzegorz Opolski, Mody F. Vaghaiwalla, Peter van der Meer, Yinong Zhou, Douglas L. Mann, Lars Kober, Gabriel Steg, Karola Jering, Ian Kulac, Carmine G. De Pasquale, John J.V. McMurray, Marc A. Pfeffer","doi":"10.1002/ejhf.3542","DOIUrl":null,"url":null,"abstract":"The relationship between body mass index (BMI) and clinical outcomes in patients with cardiovascular disease, including acute heart failure (AHF) and acute myocardial infarction (AMI), remains debated. This study investigates the association between BMI and clinical outcomes within the PARADISE-MI cohort, while also evaluating the impact of angiotensin receptor–neprilysin inhibitor (ARNI) versus angiotensin-converting enzyme inhibitor (ACE-I) treatment on this relationship.","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":"62 1","pages":""},"PeriodicalIF":16.9000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ejhf.3542","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
The relationship between body mass index (BMI) and clinical outcomes in patients with cardiovascular disease, including acute heart failure (AHF) and acute myocardial infarction (AMI), remains debated. This study investigates the association between BMI and clinical outcomes within the PARADISE-MI cohort, while also evaluating the impact of angiotensin receptor–neprilysin inhibitor (ARNI) versus angiotensin-converting enzyme inhibitor (ACE-I) treatment on this relationship.
期刊介绍:
European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.